Pharmaceutical Technology

JUNE 15, 2023

AI for drug development is rapidly streamlining R&D processes, speeding up time to market and providing a better experience for patients and providers. Learn more about the role of AI in drug development and how healthcare researchers are using it to shake up the field.

Development 130

Development Drugs Clinical Trials Clinical Trials 130

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. The same principles are increasingly being applied to clinical trials to improve diversity, mitigate bias, and reinforce inclusion in clinical trials.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

pharmaphorum

NOVEMBER 11, 2022

The lack of diversity in clinical trials has been a topic of debate for decades, but was thrust into the spotlight as the impact of the pandemic on poorer, less educated and ethnically diverse populations became even more apparent. The post IQVIA’s report card for clinical trial diversity: must do better appeared first on.

Clinical Trials 91

Clinical Trials Clinical Trials Trials Pharma Companies 91

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. David Clifton is professor of clinical machine learning in the Department of Engineering Science of the University of Oxford. Designing and generating a synthetic control arm.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Engineer 100

pharmaphorum

MAY 30, 2022

Josh Sackman, president and co-founder of AppliedVR, and Web Sun, president and co-founder of Komodo Health, relay how their newly formed collaboration reshapes the clinical trial process by using data, helping to cut costs and allowing for evaluation of broader patient populations. . Distinct offerings.

Clinical Trials 93

Clinical Trials Clinical Trials Trials Big Data 93

Intouch Solutions

OCTOBER 13, 2023

They can include the conditions in which people are born, live, learn, work, play, worship, and age 1,2 — as well as factors like economic policies and systems, development agendas, social norms, social policies and political systems. Pharmaceutical companies can develop and disperse these materials.

Pharma Companies 105

Pharma Companies Clinical Trials Clinical Trials Genetics 105

The Pharma Data

DECEMBER 20, 2020

UK drug developer Scancell said it has chosen a COVID-19 vaccine candidate, SN14, from more than a dozen potential products to advance to a clinical trial. . SN14 works by targeting the coronavirus’ nucleocapsid and spike proteins to prevent viral replication using the company’s ImmunoBody DNA vaccine technology.

Clinical Trials 52

Clinical Trials Clinical Trials Pharma Companies Vaccination 52

Drug Discovery World

OCTOBER 18, 2022

A working group has been created to measure and compare the carbon footprint of centralised (traditional site-based) and decentralised clinical trials. The Clinical Trials Environmental Impact Community of Interest (CoI) was started by Pistoia Alliance member, Syneos Health. Growing pressure on life sciences.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

XTalks

MAY 11, 2023

Clinical trials are essential for the development of new treatments for rare diseases, but they can be complex and challenging to execute. That mission is really important to me because I think it’s the only way we’re going to accelerate drug development in rare disease.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Involving patients in discussions.

Clinical Trials 91

Clinical Trials Clinical Trials Trials Clinical Research 91

XTalks

MAY 6, 2022

In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. In addition, 43.4 percent were using or piloting omics data.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

Outsourcing Pharma

NOVEMBER 15, 2021

The pharma company has completed enrollment of amyotrophic lateral sclerosis patients in its study investigating drugs like verdiperstat, an oral treatment.

Clinical Trials 69

Clinical Trials Clinical Trials Pharma Companies Trials 69

Pharmaceutical Technology

JANUARY 16, 2023

Moreover, Insilico Medicine’s INS018_055, an AI-designed candidate, has produced positive topline results in its Phase I clinical trial for idiopathic pulmonary fibrosis (IPF) treatment. In addition to collaborating with AI-technology providers, pharma companies are also engaging in vertical integration.

Big Data 303

Big Data Pharma Companies Clinical Trials Clinical Trials 303

Camargo

NOVEMBER 11, 2020

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Still, navigating such patent issues during drug development can be difficult, and Camargo can assist in finding a safe course. Ken Phelps.

Development 242

Development Bioequivalency Generic Drugs Production 242

World of DTC Marketing

JANUARY 11, 2022

As HCPs get more digitally savvy, pharma marketers should understand that engaging physicians through channels and time of their preference with content relevant to the individual customer. Key findings: 77% of HCPs use digital channels primarily for personal learning and development.

Pharma Companies 235

Pharma Companies Sales Marketing Clinical Trials 235

Pharmaceutical Technology

APRIL 13, 2023

The company is aiming to refocus its efforts on its core therapeutic areas and current late-stage programmes such as the oral TYK2 inhibitor TAK-279, which is under development for several autoimmune disorders.

Gene Therapy 243

Gene Therapy Marketing Gene In-Vivo 243

Drug Discovery World

DECEMBER 12, 2022

Biometrics contract research organisation (CRO) Phastar has joined Lean Life Science’s Oncology Development Programme (ODP2). . The targeted programme aims to identify and accelerate novel oncology innovations into commercially-attractive assets by offering support to academics and early-stage companies. .

Development 52

Development Drugs Pharma Companies Clinical Trials 52

Drug Discovery World

APRIL 20, 2023

Dr Paula Moran, Dr Kiri Granger, Dr J Mark Treherne , and Dr Jenny Barnett explore the effects of long Covid-19 symptoms and what the opportunities are for drug developers working to treat post-Covid-19 cognitive impairment. developed dementia over the subsequent two years (vs. Notably, among over-65s who had had Covid-19, 4.5%

Development 98

Development Drugs Clinical Trials Clinical Trials 98

Pharmaceutical Technology

FEBRUARY 24, 2023

The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years. The overhaul will address drug marketing exclusivity length, pricing, patient access, innovation incentives, antimicrobial resistance, clinical trials, supply chain security and shortages, and environmental impact.

Regulation 162

Regulation Clinical Trials Clinical Trials Medicine 162

The Pharma Data

OCTOBER 16, 2020

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. BetterLife conducts patient centric study via a fully remote clinical trial.

In-Vitro 52

In-Vitro Clinical Trials Clinical Trials Trials 52

Pharmaceutical Technology

JULY 21, 2022

AI also speeds up the drug development process, which could translate into cheaper drugs for patients. While large pharma companies have been slow in this area, Merck and GSK are now using 3D printing for clinical trials and manufacturing. 3D bioprinting offers an alternative to animal testing in drug development.

FDA Approval 245

FDA Approval Pharma Companies Drugs Clinical Trials 245

pharmaphorum

FEBRUARY 26, 2021

Centessa’s founder on the new company’s unique R&D model. Putting together a quarter-billion dollar pharma company from ten mergers in four months is not for the faint-hearted – but that’s what biotech investment guru Francesco de Rubertis has achieved with his latest project Centessa. Digitalising drug discovery.

Development 59

Development Research Pharma Companies Vaccination 59

Delveinsight

SEPTEMBER 3, 2021

Thus, missed or late diagnosis is a serious concern; however, it can be due to the heterogeneity of the condition, late age of onset of symptoms, slow and gradual development of symptoms, and so on. Additionally, a lack of curative and approved therapies in the CMT disease market is a serious unmet need.

Pharma Companies 52

Pharma Companies Marketing Clinical Trials Clinical Trials 52

pharmaphorum

JANUARY 17, 2022

The adoption of decentralised activities was a major factor in allowing clinical trials to continue during the early stages of the pandemic. Ben Hargreaves examines whether this adoption looks set to become a permanent feature of clinical trials moving into the future, rather than just supplying the tools to a temporary need.

Trials 105

Trials Clinical Trials Clinical Trials Clinical Research 105

World of DTC Marketing

JANUARY 10, 2022

Pharma companies are flush with cash and looking to make deals, but there are still a lot of small biotech companies that don’t have enough money to launch their products entirely. billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8 million $1228.9

Production 213

Production Drugs Development Marketing 213

XTalks

FEBRUARY 21, 2024

Clinical Trials for MASH Treatment The tirzepatide trial involved approximately 190 adults with MASH at different stages. Eli Lilly plans to present comprehensive results from this trial at an upcoming medical conference later this year. There are on-going studies to develop formulations with extended duration of action.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Insulin 59

Pharmaceutical Technology

JULY 21, 2022

In 2010, only eight big pharma companies had an access strategy for low- and middle-income countries, but today, 17 of the biggest 20 companies do. In response to the Ukraine crisis, many pharma companies are ensuring a supply of essential medicine to Ukraine and surrounding countries. Drug pricing and gouging.

Pharma Companies 130

Pharma Companies Clinical Trials Clinical Trials Drugs 130

pharmaphorum

APRIL 8, 2021

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . BioNTech seeks “new kind of pharma company”.

Development 83

Development Drugs Vaccination Vaccine 83

Drug Discovery World

JANUARY 24, 2023

Virtual clinical trials ‘Virtual’ and ‘technology’ are concepts which are readily exchanged in this industry, but these are more than just buzzwords. The overall virtual clinical trials market is currently valued at $7.8 However, it also made great strides in proving the success of these sorts of trials.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

World of DTC Marketing

NOVEMBER 27, 2020

Moderna’s top management has, collectively, sold more than $350 million in stock or investments in the company over the course of this year. Moderna’s top management has, collectively, sold more than $350 million in stock or investments in the company over the course of this year.

Vaccination 208

Vaccination Vaccine Pharma Companies Trials 208

pharmaphorum

AUGUST 26, 2021

The pandemic has transformed many aspects of our industry and one area that change has come to is patient engagement within clinical trials, where it would now seem unusual were we to not consider the patient voice when it comes to recruiting trial participants. Boosting clinical trial recruitment with digital marketing.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Marketing 105

Outsourcing Pharma

JULY 27, 2020

Elucid Digital Healthâs Pill Connect is designed to enable CROs and pharma companies to monitor patient adherence during a clinical trial.

Pharma Companies 52

Pharma Companies Clinical Trials Clinical Trials Drugs 52

World of DTC Marketing

MARCH 11, 2022

consumers’ trust in pharma is low, despite the industry’s contributions to ending the pandemic: Only 15% of U.S. consumers say they trust pharma companies more than they did before the COVID-19 pandemic, according to Accenture’s 2021 survey. What does this mean for DTC and HCP marketing?

Pharma Companies 212

Pharma Companies Vaccination Vaccine Doctors 212

pharmaphorum

FEBRUARY 4, 2022

Last year, Bayer launched a project to explore the use of artificial intelligence in clinical trials, working with Finland’s Aalto University to find ways to use the technology to support decentralised trials and streamline the testing process.

Trials 69

Trials Clinical Trials Clinical Trials Pharma Companies 69

pharmaphorum

SEPTEMBER 30, 2021

The new guidance is the first of a series that have been promised by the US regulator to develop a framework for regulating RWD, which is increasingly being used by pharma companies to investigate how their medicines perform beyond the controlled environment of clinical trials.

Pharma Companies 86

Pharma Companies Regulation Clinical Trials Clinical Trials 86

pharmaphorum

JANUARY 24, 2022

.” Those trials also need to be large, involve a diverse range of individuals, and able to be run at reduced cost, said Landray. Protas will design and run smart clinical trials through collaborations with charities, foundations, academic research teams and industry partners, and will take on both repurposed and experimental drugs.

Trials 92

Trials Drugs Clinical Trials Clinical Trials 92

The Pharma Data

DECEMBER 23, 2020

Eligible patients enrolled in the trial receive treatment with AIM’s flagship pipeline drug Ampligen. development pipeline for ME/CFS. The Ampligen EAP protocol is authorized to enroll up to 100 active trial participants, 20 of whom may be Long Haulers. Ampligen is AIM’s TLR3 agonist immune-system modulator. See: PLOS ONE ).

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drugs 52